EP1753431
Lyfjasamsetninga sem samanstanda af ZD6474.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
18.5.2005EP published:
19.8.2009EP application number:
05744858.1
EP translation filed:
9.10.2009Grant published:
15.11.2009EPO information:
European Patent Register
Max expiry date:
17.5.2025Expiry date:
17.5.2021
Title:
PHARMACEUTICAL COMPOSITIONS COMPRISING ZD6474
Timeline
Today
18.5.2005EP application
19.8.2009EP Publication
9.10.2009Translation submitted
15.11.2009Registration published
17.5.2021Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
STOTT, Paul. William,c/o AstraZenecaAddress:
Cheshire SK10 2NA, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0411378Date:
21.5.2004Country:
GB
Classification
Categories:
A61K 31/517, A61K 47/38, A61K 47/02
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 30.4.2010
Expires: 31.5.2011
Payer: Örn Þór, slf.
Number: 7
Paid: 18.3.2011
Expires: 17.5.2012
Payer: Örn Þór, slf.
Number: 8
Paid: 10.4.2012
Expires: 17.5.2013
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 9.4.2013
Expires: 17.5.2014
Payer: Árnason Faktor
Number: 10
Paid: 9.4.2014
Expires: 17.5.2015
Payer: Árnason Faktor
Number: 11
Paid: 9.4.2015
Expires: 17.5.2016
Payer: Árnason Faktor
Number: 12
Paid: 12.4.2016
Expires: 17.5.2017
Payer: Árnason Faktor
Number: 13
Paid: 10.4.2017
Expires: 17.5.2018
Payer: Árnason Faktor
Number: 14
Paid: 9.4.2018
Expires: 17.5.2019
Payer: Árnason Faktor
Number: 15
Paid: 5.4.2019
Expires: 17.5.2020
Payer: Árnason Faktor
Number: 16
Paid: 7.4.2020
Expires: 17.5.2021
Payer: Árnason Faktor ehf.